
Sanofi has said it will stop investment and research into creating new diabetes and cardiovascular drugs, as part of the …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

